Contact Information for Investors and Alliances:   Business Development: Contact  Dr. Neerja Sethi Scientific Collaborations: Contact  Dr. Karl Mettinger Investors: Contact  Investor Relations   Cellastra uniquely blends stem cell engineering, genomics, proteomics and bioinformatics within a high-throughput infrastructure for the directed characterization of human stem cells  for applications in therapeutics development.   Cellastra is playing a major role in Stem Cells Clinical and Biomedical research, and by interactions with academic and commercial partners, in the development of novel Diagnostics and Therapeutics for multiple chronic diseases.   Cellastra’s business concept incorporates developing revenue generating stem cells based research tools and long-term therapeutics development strategies for neurodegenerative diseases, diabetes and blood disorders.   Cellastra offers excellent short-term and long-term investment opportunities.